Login / Signup

5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study.

Henok Tadesse AyeleAntonios DourosKristian B Filion
Published in: British journal of clinical pharmacology (2022)
The use of 5αRIs was not associated with an increased risk of anaemia compared to the use of α-blockers among men with BPH.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • middle aged
  • iron deficiency
  • angiotensin converting enzyme